Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia

OBJECTIVE: Initial success with chimeric antigen receptor–modified T cell therapy for relapsed/refractory acute lymphoblastic leukemia is leading to expanded use through multicenter trials. Cytokine release syndrome, the most severe toxicity, presents a novel critical illness syndrome with limited d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Crit Care Med
Main Authors: Fitzgerald, Julie C., Weiss, Scott L., Maude, Shannon L., Barrett, David M., Lacey, Simon F., Melenhorst, J. Joseph, Shaw, Pamela, Berg, Robert A., June, Carl H., Porter, David L., Frey, Noelle V., Grupp, Stephan A., Teachey, David T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5452983/
https://ncbi.nlm.nih.gov/pubmed/27632680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCM.0000000000002053
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados